Promo – BioInformatics Gate

Course Content

Before You Start: Book Club Orientation

0/2

Book Club System: How It Works & How You Win

Computational Toxicology: Methods and Protocols | Book Club

0/1

Computational Toxicology: Methods and Protocols | Book Club

Chapter 1. Molecular Descriptors for Structure–Activity Applications: A Hands-On Approach

0/17

1. 1 Molecular Representation and Descriptor Dimensionality

1. 2 Classical Descriptors

1. 3 Descriptor Choice and Activity

2.3 Classification QSARs

2.4 Model Performance Evaluation

2 .7 Supplementary Material

3. 1 Structure Representation

3 .2 Descriptor Calculation

3 .3 Predictions with the CART Model

3. 4 Predictions with the KNN Model

3. 5 Bringing it all Together

Chapter 2 The OECD QSAR Toolbox Starts Its Second Decade

0/8

3 Aims, Approach, and Workflow

5 Key Elements of Using the Toolbox 5 1 Read Across

6 Current Toolbox Features and Functionalities

7 Further Development of the Toolbox

Chapter 3 QSAR What Else

0/9

2 The Three Pillars of QSAR Biological Data, Chemical Knowledge,

3 Success Stories, Pitfalls, and Trends in QSAR

4 QSAR as Induction

5 1 QSAR model validation is an essential activity to

5 2 According to Stanford Encyclopaedia of Philosophy,5 justification

5 3 Interpretability

Chapter 4 (Q)SARs as Adaptations to REACH Information Requirements

0/5

2 Adaptations to Standard Information

3 How to Use and Report QSAR

CHapter 5 Machine Learning Methods in Computational Toxicology

0/7

2 Methods 2 1 Molecular Descriptors

machine learning

2 2 2 Supervised Nonlinear Machine

2 2 3 Artificial neural networks ANNs

2 2 4 The goal of unsupervised machine learning methods is to reveal

3 Conclusions and Outlook

CHapter 6 Applicability Domain A Step Toward Confident Predictions and Decidability for QSAR Model

0/14

2 Concept of Applicability Domain

3 Concept of Decision Domain

4 Methods of Applicability Domain

4 2 Geometrical Methods 4 2 1 Convex Hull

4 3 Distance Based Methods

4 4 Probability Density Distribution

4 5 Range of the Response Variable

4 6 Miscellaneous Approaches

5 Software Employed for Applicability Domain Determination

6 How to Determine Applicability Domain Solved Examples

7 Future Direction

Chapter 7 Molecular Similarity in Computational Toxicology

0/5

1 1 Description of the Chemical

2 Material and Methods 2 1 Fingerprints

Chapter 8 Molecular Docking for Predictive Toxicology

0/9

2 Materials 2 1 Training Set

2 2 Validation Sets

2 3 Protein Target Coordinates

2 4 Docking Software

3 5 Grid Generation

Chapter 9 Criteria and Application on the Use of Nontesting Methods within a Weight of Evidence

0/5

2 The Used Nontesting Methods

Chapter 10 Characterization and Management of Uncertainties in Toxicological Risk Assessment Examples from the Opinions of the European Food Safety Authority

0/5

2 Case Study Nitrites as Food Additives

3 Use of Adverse Outcome Pathways in the Hazard Characterization

4 General Considerations and Conclusions

Chapter 11 Computational Toxicology and Drug Discovery

0/10

2 Computational Toxicology Fit for Purpose

3 Hit Identification 3 1 Compound

4 Lead Identification Lead Optimization 4 1 Structural Alerts

4 2 Secondary Pharmacology Profiling

4 3 Predicting In Vivo Effects

6 Future of Computational Toxicology

6 1 Summary and Conclusion

Chapter12 Approaching Pharmacological Space Events and Components

0/9

1 Pharmacological Space Events and Components

2 The Biological Role of the Conformational, Property and Binding Spaces

3 Conformational and Property Spaces

4 Binding Space as Assessed by Docking Simulations 4 1 Overview

4 2 Molecular Diversity and Binding

4 3 Protein Flexibility and Binding Space

4 4 Ligand Mobility as Described

Chapter 13 omputational Toxicology Methods in Chemical Library Design and High-Throughput Screening Hit Validation

0/7

2 Applications 2 1 Screening Library

2 2 A wide variety of tools have been developed for the prediction of

2 3 Structure Alerts for Reactive andor Toxic Functional Groups

3 Summary of Reactive Structure Filters

Chapter 14 Enalos Suite New Cheminformatics Platform for Drug Discovery and Computational T

0/7

2 1 Enalos Suite Database Functions

2 2 Enalos Suite

2 3 Enalos Suite Predictive Models

Chapter 15 Ion Channels in Drug Discovery and Safety Pharmacology

0/7

2 Discovery of High Affinity ClC K Ligands Starting from Pharmacovigilance Database Search

2 2 Evaluation of the Blocking

2 3 Molecular Docking Simulations

3 Preclinical Cardiac Safety

4 Conclusions and Perspectives

Chapter 16 Computational Approaches in Multitarget Drug Discovery

0/8

1 Introduction 1 1 Promise of a New Paradigm in Drug Discovery

1 2 Summary and Advantages of Our

2 Computational Studies 2 1 Antimalarials

2 5 Treatment of Influenza Virus

Chapter 17 Nanoformulations for Drug Delivery Safety, Toxicity, and Efficacy

0/8

2 Nanostructured Materials and Methods of Production of NPs

3 Treatment of NPs After Preparation, Manufacture Impurities, and Nanostability

4 Mechanisms of Interactions with CellularIntracellular Systems of NPs

5 In Vitro, In Vivo, and In Silico Nanotoxicological Assays In vitro approaches are convenient

6 In Vitro and In Vivo Case Studies for Specific NPs

7 Final Considerations

Chapter 18 Toxicity Potential of Nutraceuticals

0/12

2 Common Nutraceuticals

3 Nutraceuticals with a Toxic Potential

3 4 Green Coffee BeanCaffeine

3 10 Ephedrine Alkaloids

4 Nutraceuticals’ Safety Concern During Perioperative Care

5 1 Pyrrolizidine Alkaloids

6 Models for Nutraceuticals’ Efficacy, Safety, and Toxicity

7 Nutraceutical–Drug Interaction and Toxicity Outcome

8 Biomarkers of Nutraceuticals’ Toxic Potential

9 Management of Nutraceuticals’ Toxicity Nutraceutical induced toxicity in humans and a

Chapter 19 Impact of Pharmaceuticals on the Environment Risk Assessment Using QSAR Modeling App

0/13

2 Ecotoxicity of Pharmaceuticals

2 2 Occurrence and Effects

2 3 Pharmaceutical Hazardous Wastes and Their Treatment

3 Environmental Risk Assessment of Pharmaceuticals Risk assessment is the process of assessing

4 Environmental Risk Management of Pharmaceuticals

6 In Silico Modeling in Ecotoxicity

6 1 Why In Silico Models Required

7 Successful In Silico Models for Ecotoxicity Prediction of Pharmaceuticals

Chapter 20 QSAR Methods for Predicting Genotoxicity and Carcinogenicity Scientific Rationale

0/7

2 QSAR Methodologies

3 Predicting Genotoxicity and Carcinogenicity

4 Chemical Toxicity Databases

5 Regulatory Frameworks

Chapter 21 Stem Cell Based Methods to Predict Developmental

0/4

3 Methods 3 1 Selection

Chapter 22 Predicting Chemically Induced Skin Sensitization by Using In Chemico In Vitro Method

0/8

2 Methods 2 1 In VitroIn

2 2 In Vitro Assays

2 5 SENS IS SENS IS is an in vitro test based on a commercial human skin

2 8 IL 8 Luc Assay

2 10 Defined Approaches

Chapter 23 Hepatotoxicity Prediction by Systems Biology Modeling of Disturbed Metabolic Pathway

0/6

3 Methods 3 1 Extraction of Gene Expression Data from the LINCS

4 Example 4 1 Extraction

Chapter 24 Nontest Methods to Predict Acute Toxicity State of the Art for Applications of In Silico

0/6

3 Methods 3 1 Read Across

3 2 QSAR 3 2 1 LogKOW as Main Chemical Descriptor

Chapter 25 Predictive Systems Toxicology

0/6

1 A Brief History of Toxicology—From Sumerian Drugs to Pharmacokinetic

2 From Systems Biology to Systems Toxicology The revolution in biomedical science in the post

3 Examples of Predictive Systems Toxicology

4 Information Theoretic Approach to Toxicity

5 Concluding Remarks

Chapter 26 Chemoinformatic Approach to Assess Toxicity of Ionic Liquids

0/5

3 Methods 3 1 Dataset 3 2 Molecular Descriptors

Chapter 27 Prediction of Biochemical Endpoints by the CORAL

0/11

2 Treatment of the Dependent Variabl

3 Types of Parameter

4 CORAL Software

5 Prejudices 5 1 Prejudices

6 Selection of Endpoints 6 1 Endpoint 1

7 QSAR 7 1 QSAR Model

10 Possible Ways to Improve the Monte Carlo Technique Used in the CORAL

Computational Toxicology: Methods and Protocols | Book Club |

0% Complete